BioLineRx Ltd.'s (TLV:BLRX) Revenues Are Not Doing Enough For Some Investors
Dec 23
Have your own idea? Try our Stock Screener
Israeli (TA) Biotech Industry Analysis
UpdatedJan 02, 2026
DataAggregated Company Financials
Companies12
- 7D2.5%
- 3M0.7%
- 1Y-2.3%
- YTD0%
In the last week, the Biotech industry is up 2.5%, with Bonus BioGroup up 19%. Meanwhile, Grace Breeding actually underperformed within the industry, shrinking 12% in the last week. Despite this gain, the industry's performance has been flat over the past year. Looking forward, earnings are forecast to grow by 16% annually.
Industry Valuation and Performance
Has the Israeli Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 02 Jan 2026 | ₪2.2b | ₪628.0m | -₪63,195,366.00 | 12.4x | -34.4x | 3.5x |
| Sun, 30 Nov 2025 | ₪2.1b | ₪644.1m | -₪66,695,267.50 | 12.1x | -31.2x | 3.2x |
| Tue, 28 Oct 2025 | ₪2.1b | ₪645.4m | -₪93,991,510.00 | 13.4x | -22.8x | 3.3x |
| Thu, 25 Sep 2025 | ₪2.1b | ₪662.5m | -₪99,860,426.00 | 12.7x | -21.2x | 3.2x |
| Sat, 23 Aug 2025 | ₪2.2b | ₪669.6m | -₪133,066,649.70 | 13.3x | -16.2x | 3.2x |
| Mon, 21 Jul 2025 | ₪2.2b | ₪667.9m | -₪128,669,789.40 | 16x | -17.5x | 3.4x |
| Wed, 18 Jun 2025 | ₪2.2b | ₪695.9m | -₪130,292,679.50 | 15.4x | -16.9x | 3.2x |
| Fri, 16 May 2025 | ₪2.2b | ₪735.8m | -₪156,114,532.00 | 14.8x | -14.2x | 3x |
| Sun, 13 Apr 2025 | ₪2.0b | ₪750.2m | -₪163,015,976.20 | 14.6x | -12.5x | 2.7x |
| Tue, 11 Mar 2025 | ₪2.2b | ₪704.8m | -₪224,911,667.20 | 17x | -9.9x | 3.2x |
| Thu, 06 Feb 2025 | ₪2.1b | ₪673.1m | -₪226,287,746.60 | 15.6x | -9.5x | 3.2x |
| Sat, 04 Jan 2025 | ₪2.1b | ₪692.6m | -₪230,010,784.60 | 14.4x | -9x | 3x |
| Mon, 02 Dec 2024 | ₪2.0b | ₪689.4m | -₪226,700,012.40 | 13.5x | -8.7x | 2.9x |
| Wed, 30 Oct 2024 | ₪2.0b | ₪682.4m | -₪256,951,136.90 | 13.5x | -7.8x | 2.9x |
| Fri, 27 Sep 2024 | ₪2.1b | ₪677.6m | -₪255,803,502.20 | 13.2x | -8.1x | 3x |
| Sun, 25 Aug 2024 | ₪2.2b | ₪674.4m | -₪217,624,503.00 | 13.5x | -10x | 3.2x |
| Tue, 23 Jul 2024 | ₪2.2b | ₪627.1m | -₪324,418,360.90 | 17.2x | -6.8x | 3.5x |
| Thu, 20 Jun 2024 | ₪2.0b | ₪641.5m | -₪329,963,658.30 | 15.5x | -6.1x | 3.2x |
| Sat, 18 May 2024 | ₪2.1b | ₪598.9m | -₪382,053,327.70 | 16.4x | -5.5x | 3.5x |
| Mon, 15 Apr 2024 | ₪2.1b | ₪619.2m | -₪408,208,581.40 | 21.2x | -5.1x | 3.4x |
| Wed, 13 Mar 2024 | ₪2.3b | ₪549.1m | -₪371,170,374.00 | 54.2x | -6.3x | 4.3x |
| Fri, 09 Feb 2024 | ₪2.3b | ₪586.9m | -₪367,987,999.40 | 62.2x | -6.3x | 3.9x |
| Sun, 07 Jan 2024 | ₪2.4b | ₪629.5m | -₪399,551,706.00 | 62.8x | -6.1x | 3.9x |
| Tue, 05 Dec 2023 | ₪2.1b | ₪637.0m | -₪404,461,308.00 | 57x | -5.3x | 3.3x |
| Thu, 02 Nov 2023 | ₪2.1b | ₪646.2m | -₪426,135,624.00 | 72.3x | -4.9x | 3.2x |
| Sat, 30 Sep 2023 | ₪2.3b | ₪619.8m | -₪409,216,995.00 | 76x | -5.6x | 3.7x |
| Mon, 28 Aug 2023 | ₪1.9b | ₪615.4m | -₪339,240,215.00 | 65.3x | -5.6x | 3.1x |
| Wed, 26 Jul 2023 | ₪1.9b | ₪551.0m | -₪396,904,193.00 | n/a | -4.8x | 3.4x |
| Fri, 23 Jun 2023 | ₪1.9b | ₪538.6m | -₪390,277,976.00 | n/a | -4.9x | 3.6x |
| Sun, 21 May 2023 | ₪1.8b | ₪529.4m | -₪371,506,126.00 | n/a | -4.8x | 3.3x |
| Tue, 18 Apr 2023 | ₪1.7b | ₪607.2m | -₪443,466,292.00 | n/a | -3.8x | 2.8x |
| Thu, 16 Mar 2023 | ₪1.5b | ₪560.0m | -₪462,637,201.00 | 4.3x | -3.3x | 2.7x |
| Sat, 11 Feb 2023 | ₪1.6b | ₪547.6m | -₪471,196,784.00 | 4.7x | -3.4x | 3x |
| Mon, 09 Jan 2023 | ₪1.7b | ₪532.5m | -₪474,305,023.00 | 17.4x | -3.6x | 3.2x |
Price to Earnings Ratio
-3.6x
Current Industry PE
- Investors are relatively neutral on the Israeli Biotechs industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PS ratio of 3.3x.
Past Earnings Growth
- The earnings for companies in the Biotechs industry have improved over the last three years.
- Revenues for these companies have grown 5.7% per year.
- This means that more sales are being generated by these companies overall, and subsequently losses are decreasing too.
Industry Trends
Which industries have driven the changes within the Israeli Healthcare industry?
| IL Market | 3.89% | |
| Healthcare | -0.30% | |
| Biotech | 2.53% | |
| Biotech | 2.53% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| BONS Bonus BioGroup | ₪0.28 | 19.4% +₪52.6m | 92.4% | PE-12.7x | |
| KMDA Kamada | ₪22.62 | 0.8% +₪11.0m | -2.7% | PE20x | |
| MTLF Matricelf | ₪5.75 | 3.2% +₪5.0m | 51.6% | PB19.1x | |
| CBI Clal Biotechnology Industries | ₪0.32 | 5.5% +₪2.7m | -9.2% | PB2.1x | |
| EVGN Evogene | ₪3.34 | 1.5% +₪435.8k | -52.9% | PS1.1x |